<code id='25730EC15E'></code><style id='25730EC15E'></style>

<acronym id='25730EC15E'></acronym>

<center id='25730EC15E'><center id='25730EC15E'><tfoot id='25730EC15E'></tfoot></center><abbr id='25730EC15E'><dir id='25730EC15E'><tfoot id='25730EC15E'></tfoot><noframes id='25730EC15E'>

<optgroup id='25730EC15E'><strike id='25730EC15E'><sup id='25730EC15E'></sup></strike><code id='25730EC15E'></code></optgroup>

<b id='25730EC15E'><label id='25730EC15E'><select id='25730EC15E'><dt id='25730EC15E'><span id='25730EC15E'></span></dt></select></label></b><u id='25730EC15E'></u>

~~<i id='25730EC15E'><strike id='25730EC15E'><tt id='25730EC15E'><pre id='25730EC15E'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

explore

author：knowledge 2025-09-28 18:42:14 Page View：87

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Statins may not be needed by millions of people, study suggests
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

explore

Malaria cases in Florida and Texas: Here’s what you need to know

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Senate panel puts off hardest PBM reforms for another day

Senate panel puts off hardest PBM reforms for another day

SenateFinanceCommitteeChairRonWyden(D-Ore.)LeahMillis/PoolviaAPWASHINGTON—SenatorsontheFinanceCommit

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

CTscansshowedthatthepatientinitiallyrespondedtolorlatinib(left).Buteightmonthslater,themetastaticliv

read more